GBA Medical Device Services, a part of GBA Group, is excited to announce the expansion of its service portfolio to include high-performance liquid chromatography (HPLC) analyses for the characterization of non-volatile organic compounds (NVOC).

GBA Medical Device Services, a part of GBA Group, is excited to announce the expansion of its service portfolio to include high-performance liquid chromatography (HPLC) analyses for the characterization of non-volatile organic compounds (NVOC).

Are you facing challenges with your laboratory's number formats and barcode systems? Are you unsure if your current provider can handle different formats, especially those of foreign laboratories?

We are excited to announce that GBA Group Pharma & Medical Devices has successfully achieved the MA State License for GBA CLS (Central Laboratory Services) for Pharma testing in Boston, Massachusetts.

With the acquisition of the Swedish company Key2Compliance AB, GBA Group is expanding its range of consulting and training services for the medical device, In Vitro Diagnostics (IVD), and pharmaceutical industry. GBA Group is thus taking another important step towards establishing itself as a broad service provider for international customers in this area.

Introducing the latest equipment, including a new cobas® pure system from Roche and Hitachi, as well as a sophisticated hematology analyzer from Sysmex Corporation. These technologies enable us to analyze and assess your samples at the highest level, ensuring accuracy and efficiency at every step.